Your browser doesn't support javascript.
loading
Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors.
Thornton, Christopher D; Fielding, Stuart; Karbowniczek, Kinga; Roig-Merino, Alicia; Burrows, Alysha E; FitzPatrick, Lorna M; Sharaireh, Aseel; Tite, John P; Mole, Sara E; Harbottle, Richard P; Caproni, Lisa J; McKay, Tristan R.
Affiliation
  • Thornton CD; Centre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
  • Fielding S; Medicines Discovery Catapult, Alderley Park, Cheshire, UK.
  • Karbowniczek K; Centre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
  • Roig-Merino A; Touchlight Genetics Ltd, Hampton, UK.
  • Burrows AE; Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
  • FitzPatrick LM; Centre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
  • Sharaireh A; Centre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
  • Tite JP; Medicines Discovery Catapult, Alderley Park, Cheshire, UK.
  • Mole SE; Centre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
  • Harbottle RP; Touchlight Genetics Ltd, Hampton, UK.
  • Caproni LJ; MRC Laboratory for Molecular Biology and GOS Institute for Child Health, University College London, London, UK.
  • McKay TR; Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
Mol Ther Methods Clin Dev ; 23: 348-358, 2021 Dec 10.
Article in En | MEDLINE | ID: mdl-34729381
ABSTRACT
The application of induced pluripotent stem cells (iPSCs) in advanced therapies is increasing at pace, but concerns remain over their clinical safety profile. We report the first-ever application of doggybone DNA (dbDNA) vectors to generate human iPSCs. dbDNA vectors are closed-capped linear double-stranded DNA gene expression cassettes that contain no bacterial DNA and are amplified by a chemically defined, current good manufacturing practice (cGMP)-compliant methodology. We achieved comparable iPSC reprogramming efficiencies using transiently expressing dbDNA vectors with the same iPSC reprogramming coding sequences as the state-of-the-art OriP/EBNA1 episomal vectors but, crucially, in the absence of p53 shRNA repression. Moreover, persistent expression of EBNA1 from bacterially derived episomes resulted in stimulation of the interferon response, elevated DNA damage, and increased spontaneous differentiation. These cellular activities were diminished or absent in dbDNA-iPSCs, resulting in lines with a greater stability and safety potential for cell therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Methods Clin Dev Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Methods Clin Dev Year: 2021 Document type: Article Affiliation country: United kingdom